Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-NMI Recombinant Antibody (9D8) (CBMAB-N0430-WJ)

Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
9D8
Antibody Isotype
IgG2b, κ
Application
ELISA, IHC, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG2b, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.2
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
N-Myc And STAT Interactor
Introduction
NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008]
Entrez Gene ID
UniProt ID
Alternative Names
N-Myc And STAT Interactor; N-Myc (And STAT) Interactor; N-Myc-Interactor; NMI;
Function
Acts as a signaling pathway regulator involved in innate immune system response (PubMed:9989503, PubMed:26342464, PubMed:29038465, PubMed:29350881).
In response to interleukin 2/IL2 and interferon IFN-gamma/IFNG, interacts with signal transducer and activator of transcription/STAT which activate the transcription of downstream genes involved in a multitude of signals for development and homeostasis (PubMed:9989503, PubMed:29377960).
Enhances the recruitment of CBP/p300 coactivators to STAT1 and STAT5, resulting in increased STAT1- and STAT5-dependent transcription (PubMed:9989503).
In response to interferon IFN-alpha, associates in a complex with signaling pathway regulator IFI35 to regulate immune response; the complex formation prevents proteasome-mediated degradation of IFI35 (PubMed:10779520, PubMed:10950963).
In complex with IFI35, inhibits virus-triggered type I IFN-beta production when ubiquitinated by ubiquitin-protein ligase TRIM21 (PubMed:26342464).
In complex with IFI35, negatively regulates nuclear factor NF-kappa-B signaling by inhibiting the nuclear translocation, activation and transcription of NF-kappa-B subunit p65/RELA, resulting in the inhibition of endothelial cell proliferation, migration and re-endothelialization of injured arteries (PubMed:29350881).
Negatively regulates virus-triggered type I interferon/IFN production by inducing proteosome-dependent degradation of IRF7, a transcriptional regulator of type I IFN, thereby interfering with cellular antiviral responses (By similarity).
Beside its role as an intracellular signaling pathway regulator, also functions extracellularly as damage-associated molecular patterns (DAMPs) to promote inflammation, when actively released by macrophage to the extracellular space during cell injury or pathogen invasion (PubMed:29038465).
Macrophage-secreted NMI activates NF-kappa-B signaling in adjacent macrophages through Toll-like receptor 4/TLR4 binding and activation, thereby inducing NF-kappa-B translocation from the cytoplasm into the nucleus which promotes the release of pro-inflammatory cytokines (PubMed:29038465).
Biological Process
Interferon-gamma-mediated signaling pathwayIEA:InterPro
Macrophage activation involved in immune responseManual Assertion Based On ExperimentIDA:UniProtKB
Negative regulation of cell population proliferationManual Assertion Based On ExperimentIMP:UniProtKB
Negative regulation of innate immune responseManual Assertion Based On ExperimentIMP:UniProtKB
Negative regulation of interferon-alpha productionIEA:Ensembl
Negative regulation of interferon-beta productionIEA:Ensembl
Negative regulation of NIK/NF-kappaB signalingManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of inflammatory responseISS:UniProtKB
Positive regulation of innate immune responseISS:UniProtKB
Positive regulation of NIK/NF-kappaB signalingManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of protein K48-linked ubiquitinationIEA:Ensembl
Receptor signaling pathway via JAK-STATManual Assertion Based On ExperimentTAS:UniProtKB
Response to virusISS:UniProtKB
Toll-like receptor 4 signaling pathwayISS:UniProtKB
Transcription by RNA polymerase IIIEA:InterPro
Cellular Location
Cytoplasm
Nucleus
Secreted
Cytoplasmic NMI localizes in punctate granular structures (PubMed:9781816, PubMed:10950963).
Nuclear localization increased following IFN-alpha treatment (PubMed:9781816, PubMed:10950963).
Extracelullar following secretion by macrophage (PubMed:29038465).
PTM
Ubiquitinated. 'Lys-63'-linked ubiquitination by TRIM21 promotes interaction with IFI35 and inhibits virus-triggered type I IFN-beta production.
More Infomation

Hu, H., Li, B., Chen, H., Fan, G., Ye, Z., Ji, S., ... & Qin, Y. (2024). NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3‐IFIT3 axis. Molecular Carcinogenesis, 63(2), 195-208.

Feng, L., Li, W., Li, X., Li, X., Ran, Y., Yang, X., ... & Li, H. (2023). N‐MYC‐interacting protein enhances type II interferon signaling by inhibiting STAT1 sumoylation. The FASEB Journal, 37(12), e23281.

Li, L., Chen, S. N., Li, N., & Nie, P. (2022). Molecular characterization and transcriptional conservation of N-myc-interactor, Nmi, by type I and type II IFNs in mandarin fish Siniperca chuatsi. Developmental & Comparative Immunology, 130, 104354.

Zhang, W., Zhou, H., Cen, M., Ouyang, W., Chen, J., Xia, L., ... & Xu, F. (2022). N-myc and STAT interactor is a novel biomarker of severity in community-acquired pneumonia: a prospective study. Respiratory Research, 23(1), 1-11.

Banday, M. M., Kumar, A., Vestal, G., Sethi, J., Patel, K. N., O'Neill, E. B., ... & Sharma, N. S. (2021). N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation, 40(6), 447-457.

Wu, S., Li, X., Chai, H., Feng, L., Li, W., & Li, H. (2021). Downregulation of N-myc interactor promotes cervical cancer cells growth by activating Stat3 signaling. Cell Biochemistry and Biophysics, 79, 103-111.

Ji, D., Feng, Y., Peng, W., Li, J., Gu, Q. O., Zhang, Z., ... & Sun, Y. (2020). NMI promotes cell proliferation through TGFβ/Smad pathway by upregulating STAT1 in colorectal cancer. Journal of Cellular Physiology, 235(1), 429-441.

Choi, J. E., Hyun, C. L., Jin, M. S., Lee, K. M., Moon, J. H., & Ryu, H. S. (2020). Downregulation of N-myc and STAT interactor protein predicts aggressive tumor behavior and poor prognosis in invasive ductal carcinoma. Journal of Breast Cancer, 23(1), 36-46.

Xia, J., Blank, M. L., Zhou, L. J., Wu, S. Z., Peng, H. J., & Boyle, J. P. (2020). Strain-specific disruption of interferon-stimulated N-myc and STAT interactor (NMI) function by Toxoplasma gondii type I ROP18 in human cells. Parasitology, 147(13), 1433-1442.

Xiong, L., Du, Y., Zhou, T., Du, B., Visalath, P., Lin, L., ... & Cai, W. (2019). N‐myc and STAT interactor correlates with severity and prognosis in acute‐on‐chronic liver failure of hepatitis B virus. Journal of Gastroenterology and Hepatology, 34(10), 1800-1808.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-NMI Recombinant Antibody (9D8)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Online Inquiry